These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22511462)

  • 1. Small-for-size syndrome after living donor liver transplantation: successful treatment with a transjugular intrahepatic portosystemic shunt.
    Xiao L; Li F; Wei B; Li B; Tang CW
    Liver Transpl; 2012 Sep; 18(9):1118-20. PubMed ID: 22511462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome.
    Botha JF; Langnas AN; Campos BD; Grant WJ; Freise CE; Ascher NL; Mercer DF; Roberts JP
    Liver Transpl; 2010 May; 16(5):649-57. PubMed ID: 20440774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature.
    Campos-Varela I; Castells L; Dopazo C; Pérez-Lafuente M; Allende H; Len O; Llopart L; Vargas V; Charco R
    Liver Transpl; 2012 Feb; 18(2):201-5. PubMed ID: 21656652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunt following liver transplantation: can outcomes be predicted?
    El Atrache M; Abouljoud M; Sharma S; Abbass AA; Yoshida A; Kim D; Kazimi M; Moonka D; Brown K
    Clin Transplant; 2012; 26(4):657-61. PubMed ID: 22309034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of small-for-size syndrome in adult-to-adult living-related liver transplantation: single center series.
    Gruttadauria S; Mandala' L; Miraglia R; Caruso S; Minervini MI; Biondo D; Volpes R; Vizzini G; Marsh JW; Luca A; Marcos A; Gridelli B
    Clin Transplant; 2007; 21(6):761-6. PubMed ID: 17988271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transjugular intrahepatic portosystemic stent-shunt after orthotopic liver transplantation in a patient with early recurrence of portal hypertension of unknown origin.
    Nolte W; Canelo R; Figulla HR; Kersten J; Sattler B; Münke H; Hartmann H; Ringe B; Ramadori G
    Z Gastroenterol; 1998 Feb; 36(2):159-64. PubMed ID: 9544499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-for-size syndrome in liver transplantation: Definition, pathophysiology and management.
    Masuda Y; Yoshizawa K; Ohno Y; Mita A; Shimizu A; Soejima Y
    Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):334-341. PubMed ID: 32646775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt.
    Therapondos G; Wong F
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1161-6. PubMed ID: 17033435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before.
    Ogura Y; Hori T; El Moghazy WM; Yoshizawa A; Oike F; Mori A; Kaido T; Takada Y; Uemoto S
    Liver Transpl; 2010 Jun; 16(6):718-28. PubMed ID: 20517905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related liver transplant recipient candidates: preliminary results.
    Saad WE; Saad NE; Davies MG; Bozorgdadeh A; Orloff MS; Patel NC; Abt PL; Lee DE; Sahler LG; Kitanosono T; Sasson T; Waldman DL
    J Vasc Interv Radiol; 2006 Jun; 17(6):995-1002. PubMed ID: 16778233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed splenic artery occlusion for treatment of established small-for-size syndrome after partial liver transplantation.
    Humar A; Beissel J; Crotteau S; Cohen M; Lake J; Payne WD
    Liver Transpl; 2009 Feb; 15(2):163-8. PubMed ID: 19177447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt.
    Senzolo M; Patch D; Cholongitas E; Triantos C; Marelli L; Stigliano R; Dhillon A; Burroughs A
    Transplantation; 2006 Jul; 82(1):132-5. PubMed ID: 16861953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical considerations in liver transplantation: small for size syndrome.
    Selvaggi G; Tzakis A
    Panminerva Med; 2009 Dec; 51(4):227-33. PubMed ID: 20195233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt for intractable posthepatectomy ascites.
    Hwang S; Park KM; Lee SG; Sung KB; Lee YJ; Choi DN; Ahn CS; Min PC
    Hepatogastroenterology; 2002; 49(48):1669-72. PubMed ID: 12397761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients.
    Choi DX; Jain AB; Orloff MS
    J Am Coll Surg; 2009 Apr; 208(4):539-46. PubMed ID: 19476787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of SFSS in adult-to-adult living donor liver transplantation using the right liver: a single-center analysis of 217 cases.
    Lei JY; Wang WT; Yan LN
    Hepatogastroenterology; 2012; 59(117):1491-7. PubMed ID: 22094994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MELD score less than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation.
    Feyssa E; Ortiz J; Grewal K; Azhar A; Parsikia A; Tufail K; Hashemi N; Brady P; Araya V
    Transplantation; 2011 Apr; 91(7):786-92. PubMed ID: 21304440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
    Ochs A; Rössle M; Haag K; Hauenstein KH; Deibert P; Siegerstetter V; Huonker M; Langer M; Blum HE
    N Engl J Med; 1995 May; 332(18):1192-7. PubMed ID: 7700312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.